IBANDRONATE SODIUM
Aurobindo Pharma gets final USFDA nod for osteoporosis drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...
Aurobindo Pharma gets USFDA nod to market ulcer drugThe company's approved abbreviated new drug application (ANDA) is a generic version of AstraZeneca Pharmaceuticals' Prilosec capsules, it a...- Dr Reddy's launches osteoporosis tablets in USDr Reddy's Laboratories today said it has launched generic tablets used for treating post- menopausal osteoporosis in the American market.
- Natco launches drug for bone diseaseNatco Pharma Ltd on Tuesday said it has launched Ibandronate Sodium, a drug used in the treatment of metastatic bone disease, in tablet and...
Load More- Natco launches drug for bone disease